BBHC
CYTK icon

Brown Brothers Harriman & Co’s Cytokinetics CYTK Stock Holding History

Brown Brothers Harriman & Co’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.8K Hold
300
– – ﹤0.01% 1233
2025
Q4 		$19.1K Buy
+300
New +$18.7K ﹤0.01% 1220
2023
Q1 		– Sell
-100
Closed -$4.58K – 1282
2022
Q4 		$4.58K Hold
100
– – ﹤0.01% 1110
2022
Q3 		$5K Hold
100
– – ﹤0.01% 1287
2022
Q2 		$4K Hold
100
– – ﹤0.01% 1167
2022
Q1 		$4K Buy
+100
New +$3.55K ﹤0.01% 1141

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return